Xiaowei Zhang

No. 270, Dong An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence era.

Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence era.

Journal: Biomarker research
Published: April 02, 2026

Tandem Duplication-Driven Neofunctionalization of UDP-Glycosyltransferases Shapes the Diversification of Triterpenoid Saponins in the Cucurbitaceae.

Tandem Duplication-Driven Neofunctionalization of UDP-Glycosyltransferases Shapes the Diversification of Triterpenoid Saponins in the Cucurbitaceae.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 23, 2026

Multimodal parameters for the diagnosis of putative primaries of cancer of unknown primary.

Multimodal parameters for the diagnosis of putative primaries of cancer of unknown primary.

Journal: iScience
Published: October 16, 2025

Machine learning-driven proteomics classifier deciphers tumor origins of primary and metastatic squamous cell carcinomas.

Machine learning-driven proteomics classifier deciphers tumor origins of primary and metastatic squamous cell carcinomas.

Journal: Biomarker research
Published: September 01, 2025

Fruquintinib as first-line or second-line treatment in unresectable or metastatic soft-tissue sarcoma: A prospective, single-arm phase II study.

Fruquintinib as first-line or second-line treatment in unresectable or metastatic soft-tissue sarcoma: A prospective, single-arm phase II study.

Journal: Clinical and translational medicine
Published: February 25, 2025

Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis.

Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis.

Journal: Frontiers in oncology
Published: December 01, 2024

Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.

Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.

Journal: MedComm
Published: October 15, 2024

De novo synthesis of 1-phenethylisoquinoline in engineered Escherichia coli.

De novo synthesis of 1-phenethylisoquinoline in engineered Escherichia coli.

Journal: Synthetic and systems biotechnology
Published: August 17, 2024

Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance.

Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance.

Journal: Cancer biology & therapy
Published: January 30, 2024

The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis.

The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis.

Journal: Cell death & disease
Published: December 06, 2023

An integrative database and its application for plant synthetic biology research.

An integrative database and its application for plant synthetic biology research.

Journal: Plant communications
Published: October 31, 2023

A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer.

A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer.

Journal: Therapeutic advances in medical oncology
Published: September 07, 2023
Showing 1-12 of 58

Last Updated: 09/26/2026